Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mef2c
|
ENSMUSG00000005583.10 | myocyte enhancer factor 2C |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_83655223_83655396 | Mef2c | 2421 | 0.287857 | -0.78 | 2.1e-12 | Click! |
chr13_83565771_83566074 | Mef2c | 6426 | 0.287640 | 0.76 | 2.4e-11 | Click! |
chr13_83532073_83532230 | Mef2c | 2013 | 0.453674 | 0.75 | 4.1e-11 | Click! |
chr13_83655493_83655806 | Mef2c | 2761 | 0.266118 | -0.71 | 1.2e-09 | Click! |
chr13_83661208_83661451 | Mef2c | 8441 | 0.183622 | -0.71 | 1.8e-09 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_128206282_128206464 | 33.16 |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
14 |
0.94 |
chr2_163392547_163392724 | 30.74 |
Jph2 |
junctophilin 2 |
5314 |
0.15 |
chr14_23243993_23244151 | 30.36 |
Gm46443 |
predicted gene, 46443 |
77072 |
0.12 |
chr14_47747632_47747852 | 28.72 |
4930538L07Rik |
RIKEN cDNA 4930538L07 gene |
9744 |
0.16 |
chr4_82133017_82133195 | 26.51 |
Gm5860 |
predicted gene 5860 |
67149 |
0.11 |
chr16_96213128_96213298 | 24.71 |
Sh3bgr |
SH3-binding domain glutamic acid-rich protein |
6570 |
0.16 |
chr14_26441437_26441768 | 24.52 |
Slmap |
sarcolemma associated protein |
1053 |
0.48 |
chr11_77800834_77801396 | 23.85 |
Myo18a |
myosin XVIIIA |
183 |
0.93 |
chr14_63247857_63248018 | 23.81 |
Gata4 |
GATA binding protein 4 |
2666 |
0.25 |
chr2_120098846_120099211 | 23.45 |
Sptbn5 |
spectrin beta, non-erythrocytic 5 |
13350 |
0.14 |
chr3_79989222_79989588 | 23.16 |
A330069K06Rik |
RIKEN cDNA A330069K06 gene |
65487 |
0.1 |
chr2_6099009_6099213 | 22.95 |
Proser2 |
proline and serine rich 2 |
31028 |
0.13 |
chr1_30786618_30786815 | 22.27 |
Gm2914 |
predicted gene 2914 |
8159 |
0.16 |
chr17_78791164_78791351 | 21.66 |
Heatr5b |
HEAT repeat containing 5B |
4856 |
0.16 |
chr19_53716555_53716887 | 21.65 |
Rbm20 |
RNA binding motif protein 20 |
39415 |
0.13 |
chr6_115694501_115694848 | 21.62 |
Raf1 |
v-raf-leukemia viral oncogene 1 |
18039 |
0.1 |
chr13_46413709_46413871 | 21.53 |
Rbm24 |
RNA binding motif protein 24 |
4644 |
0.27 |
chr1_91217012_91217176 | 21.49 |
Ube2f |
ubiquitin-conjugating enzyme E2F (putative) |
33210 |
0.11 |
chr1_129101142_129101329 | 21.43 |
Thsd7b |
thrombospondin, type I, domain containing 7B |
172067 |
0.03 |
chr5_30604744_30604914 | 21.11 |
Gm9899 |
predicted gene 9899 |
16210 |
0.12 |
chr11_55085489_55085675 | 20.14 |
Ccdc69 |
coiled-coil domain containing 69 |
7451 |
0.13 |
chr1_170622997_170623376 | 20.07 |
Gm7299 |
predicted gene 7299 |
7735 |
0.19 |
chr7_48848017_48848204 | 19.99 |
Csrp3 |
cysteine and glycine-rich protein 3 |
77 |
0.96 |
chr14_20664487_20664751 | 19.73 |
Synpo2l |
synaptopodin 2-like |
45 |
0.94 |
chr16_78259119_78259283 | 19.25 |
E330011O21Rik |
RIKEN cDNA E330011O21 gene |
4665 |
0.18 |
chr9_44493089_44493524 | 19.21 |
Bcl9l |
B cell CLL/lymphoma 9-like |
5001 |
0.08 |
chr13_9127819_9127973 | 19.17 |
Larp4b |
La ribonucleoprotein domain family, member 4B |
8319 |
0.16 |
chr13_46427501_46427664 | 19.17 |
Rbm24 |
RNA binding motif protein 24 |
5760 |
0.25 |
chr4_152262207_152262502 | 19.04 |
Gpr153 |
G protein-coupled receptor 153 |
11878 |
0.12 |
chr15_93698317_93698645 | 19.03 |
Gm41386 |
predicted gene, 41386 |
14288 |
0.19 |
chr7_67055544_67055862 | 18.83 |
Adamts17 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17 |
8232 |
0.2 |
chr7_19756162_19756518 | 18.80 |
Bcam |
basal cell adhesion molecule |
611 |
0.48 |
chr18_61447379_61448092 | 18.64 |
Gm8755 |
predicted gene 8755 |
13534 |
0.12 |
chr11_116104002_116104330 | 18.57 |
Trim47 |
tripartite motif-containing 47 |
2917 |
0.13 |
chr4_154701020_154701175 | 18.25 |
Actrt2 |
actin-related protein T2 |
33230 |
0.12 |
chr17_26490930_26491240 | 18.11 |
Gm34455 |
predicted gene, 34455 |
163 |
0.92 |
chr14_31209142_31209517 | 18.04 |
Tnnc1 |
troponin C, cardiac/slow skeletal |
997 |
0.35 |
chr12_11204437_11204612 | 17.99 |
9530020I12Rik |
RIKEN cDNA 9530020I12 gene |
22 |
0.97 |
chr6_29923626_29923783 | 17.84 |
Strip2 |
striatin interacting protein 2 |
6691 |
0.13 |
chr15_96059781_96059932 | 17.83 |
D030018L15Rik |
RIKEN cDNA D030018L15 gene |
5031 |
0.27 |
chr3_52983866_52984073 | 17.59 |
Cog6 |
component of oligomeric golgi complex 6 |
10716 |
0.15 |
chr13_91877371_91877615 | 17.43 |
Ckmt2 |
creatine kinase, mitochondrial 2 |
608 |
0.75 |
chr4_156215652_156215940 | 17.43 |
Perm1 |
PPARGC1 and ESRR induced regulator, muscle 1 |
72 |
0.94 |
chr2_114054212_114054414 | 17.34 |
C130080G10Rik |
RIKEN cDNA C130080G10 gene |
22 |
0.94 |
chr11_116523152_116523303 | 17.14 |
Sphk1 |
sphingosine kinase 1 |
7698 |
0.09 |
chr11_100912853_100913037 | 17.09 |
Stat3 |
signal transducer and activator of transcription 3 |
4721 |
0.16 |
chr1_184041939_184042195 | 17.04 |
Dusp10 |
dual specificity phosphatase 10 |
7686 |
0.23 |
chr12_24912247_24912398 | 17.00 |
Kidins220 |
kinase D-interacting substrate 220 |
62603 |
0.09 |
chr16_30737096_30737261 | 16.57 |
Gm49754 |
predicted gene, 49754 |
56077 |
0.11 |
chr4_139433058_139433245 | 16.53 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
1859 |
0.31 |
chr3_105375456_105375628 | 16.44 |
Kcnd3os |
potassium voltage-gated channel, Shal-related family, member 3, opposite strand |
76185 |
0.09 |
chr7_81683900_81684074 | 16.35 |
Homer2 |
homer scaffolding protein 2 |
8900 |
0.14 |
chr1_23187823_23188209 | 16.28 |
Gm29506 |
predicted gene 29506 |
47657 |
0.11 |
chr2_15538711_15539023 | 16.27 |
Gm37595 |
predicted gene, 37595 |
7754 |
0.22 |
chr12_86104369_86104717 | 16.21 |
Ift43 |
intraflagellar transport 43 |
12421 |
0.15 |
chr5_35985697_35985902 | 16.18 |
Afap1 |
actin filament associated protein 1 |
1206 |
0.58 |
chr5_124234197_124234379 | 16.04 |
Gm42425 |
predicted gene 42425 |
3436 |
0.14 |
chr3_101026724_101027123 | 16.03 |
Cd101 |
CD101 antigen |
2633 |
0.27 |
chr7_81078760_81079054 | 15.90 |
Alpk3 |
alpha-kinase 3 |
15924 |
0.13 |
chr3_152133730_152133901 | 15.87 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
3955 |
0.16 |
chr4_151083147_151083315 | 15.86 |
Camta1 |
calmodulin binding transcription activator 1 |
3438 |
0.2 |
chr15_36855074_36855317 | 15.86 |
Gm49282 |
predicted gene, 49282 |
12379 |
0.16 |
chr1_119194615_119194770 | 15.77 |
Gm8321 |
predicted gene 8321 |
37106 |
0.16 |
chr5_24127075_24127226 | 15.72 |
Gm3724 |
predicted gene 3724 |
8486 |
0.13 |
chr5_123662041_123662352 | 15.66 |
Clip1 |
CAP-GLY domain containing linker protein 1 |
4494 |
0.13 |
chr2_76806390_76806720 | 15.59 |
Ttn |
titin |
19987 |
0.22 |
chr8_95596782_95597294 | 15.59 |
Gm31518 |
predicted gene, 31518 |
3516 |
0.13 |
chr7_143364230_143364381 | 15.54 |
4933417O13Rik |
RIKEN cDNA 4933417O13 gene |
320 |
0.85 |
chr11_76125506_76125804 | 15.54 |
Vps53 |
VPS53 GARP complex subunit |
13093 |
0.16 |
chr13_93399765_93399921 | 15.46 |
Gm47155 |
predicted gene, 47155 |
10940 |
0.16 |
chr7_118252283_118252447 | 15.46 |
4930583K01Rik |
RIKEN cDNA 4930583K01 gene |
8500 |
0.13 |
chr17_49489183_49489354 | 15.42 |
Mocs1 |
molybdenum cofactor synthesis 1 |
36984 |
0.17 |
chr8_88334428_88334728 | 15.39 |
Brd7 |
bromodomain containing 7 |
657 |
0.72 |
chr15_89415394_89415558 | 15.30 |
Syce3 |
synaptonemal complex central element protein 3 |
4973 |
0.08 |
chr4_135002364_135002805 | 15.25 |
Syf2 |
SYF2 homolog, RNA splicing factor (S. cerevisiae) |
71574 |
0.08 |
chr9_43945084_43945256 | 15.23 |
Gm30373 |
predicted gene, 30373 |
25001 |
0.1 |
chr11_3509274_3509435 | 15.22 |
Inpp5j |
inositol polyphosphate 5-phosphatase J |
4533 |
0.1 |
chr6_97265307_97265633 | 15.12 |
Lmod3 |
leiomodin 3 (fetal) |
12711 |
0.17 |
chr8_110676672_110677057 | 15.10 |
Vac14 |
Vac14 homolog (S. cerevisiae) |
31284 |
0.14 |
chr6_116072792_116072963 | 15.00 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
279 |
0.9 |
chr14_78548962_78549138 | 14.96 |
Akap11 |
A kinase (PRKA) anchor protein 11 |
12242 |
0.19 |
chr1_90398483_90398916 | 14.95 |
Gm28722 |
predicted gene 28722 |
55802 |
0.12 |
chr5_74147556_74147712 | 14.85 |
A330058E17Rik |
RIKEN cDNA A330058E17 gene |
28416 |
0.11 |
chr13_80535871_80536087 | 14.80 |
Gm46388 |
predicted gene, 46388 |
42970 |
0.21 |
chr12_16391867_16392199 | 14.76 |
Gm48605 |
predicted gene, 48605 |
159806 |
0.03 |
chr2_17624092_17624243 | 14.74 |
Mir6419 |
microRNA 6419 |
60653 |
0.12 |
chr14_120299658_120299977 | 14.70 |
Mbnl2 |
muscleblind like splicing factor 2 |
2143 |
0.41 |
chr6_97265769_97265981 | 14.70 |
Lmod3 |
leiomodin 3 (fetal) |
13116 |
0.17 |
chr9_88276128_88276309 | 14.69 |
Gm5066 |
predicted gene 5066 |
4972 |
0.17 |
chr6_93257695_93257846 | 14.57 |
Gm44220 |
predicted gene, 44220 |
16050 |
0.23 |
chr6_86832842_86833107 | 14.57 |
2610306M01Rik |
RIKEN cDNA 2610306M01 gene |
16466 |
0.12 |
chr11_101030536_101030719 | 14.57 |
Mir6928 |
microRNA 6928 |
287 |
0.83 |
chr2_154192262_154192416 | 14.55 |
Bpifb1 |
BPI fold containing family B, member 1 |
1516 |
0.31 |
chr14_31659585_31659876 | 14.54 |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
18444 |
0.13 |
chr8_13209906_13210098 | 14.42 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
9182 |
0.1 |
chr11_119733134_119733291 | 14.35 |
Gm23663 |
predicted gene, 23663 |
13189 |
0.2 |
chr6_82760794_82760976 | 14.32 |
Gm17034 |
predicted gene 17034 |
3397 |
0.18 |
chr2_180385219_180385870 | 14.31 |
B230312C02Rik |
RIKEN cDNA B230312C02 gene |
341 |
0.82 |
chr16_8232120_8232322 | 14.31 |
Gm26159 |
predicted gene, 26159 |
104772 |
0.07 |
chr11_108165912_108166135 | 14.21 |
Gm11655 |
predicted gene 11655 |
15827 |
0.25 |
chr8_124643910_124644289 | 14.21 |
2310022B05Rik |
RIKEN cDNA 2310022B05 gene |
19270 |
0.14 |
chr11_101842419_101842595 | 14.19 |
Gm11551 |
predicted gene 11551 |
43730 |
0.09 |
chr14_61161886_61162184 | 14.17 |
Sacs |
sacsin |
10955 |
0.21 |
chr5_133487764_133488091 | 14.10 |
Gm10051 |
predicted pseudogene 10051 |
12804 |
0.21 |
chr6_134182379_134182967 | 14.08 |
Gm17088 |
predicted gene 17088 |
10666 |
0.19 |
chr17_35549462_35549916 | 14.08 |
Cdsn |
corneodesmosin |
2439 |
0.12 |
chr6_5509305_5509636 | 14.05 |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
13161 |
0.28 |
chr6_71262512_71262719 | 14.04 |
Smyd1 |
SET and MYND domain containing 1 |
334 |
0.79 |
chr11_77423532_77423841 | 14.03 |
Ssh2 |
slingshot protein phosphatase 2 |
32249 |
0.12 |
chr11_97669816_97670137 | 13.99 |
Mllt6 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 6 |
4975 |
0.09 |
chr9_120023495_120024031 | 13.98 |
Xirp1 |
xin actin-binding repeat containing 1 |
165 |
0.9 |
chr19_24308225_24308734 | 13.97 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
8863 |
0.18 |
chr4_152317793_152318019 | 13.83 |
Rnf207 |
ring finger protein 207 |
552 |
0.63 |
chr15_86109692_86110004 | 13.78 |
Gm15722 |
predicted gene 15722 |
19788 |
0.16 |
chr12_86498783_86499128 | 13.77 |
Esrrb |
estrogen related receptor, beta |
5454 |
0.28 |
chr7_110156726_110157216 | 13.72 |
1600010M07Rik |
RIKEN cDNA 1600010M07 gene |
5769 |
0.16 |
chr6_33049847_33049998 | 13.67 |
Gm42895 |
predicted gene 42895 |
7803 |
0.18 |
chr12_73781530_73781966 | 13.66 |
Gm8075 |
predicted gene 8075 |
11735 |
0.21 |
chr18_74704089_74704286 | 13.63 |
Myo5b |
myosin VB |
3319 |
0.27 |
chr1_184171018_184171191 | 13.59 |
Dusp10 |
dual specificity phosphatase 10 |
136723 |
0.04 |
chr1_186587142_186587307 | 13.58 |
A730004F24Rik |
RIKEN cDNA A730004F24 gene |
28543 |
0.18 |
chr1_168180641_168181019 | 13.58 |
Pbx1 |
pre B cell leukemia homeobox 1 |
16168 |
0.28 |
chr19_40377067_40377270 | 13.45 |
Sorbs1 |
sorbin and SH3 domain containing 1 |
294 |
0.92 |
chr7_139467914_139468274 | 13.41 |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
13539 |
0.24 |
chr14_25488148_25488359 | 13.41 |
Gm47921 |
predicted gene, 47921 |
8199 |
0.14 |
chr5_122100700_122101295 | 13.34 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
14 |
0.97 |
chr17_47850142_47850294 | 13.31 |
n-R5s28 |
nuclear encoded rRNA 5S 28 |
1384 |
0.31 |
chr7_99255057_99255208 | 13.31 |
Gm18943 |
predicted gene, 18943 |
6312 |
0.13 |
chr7_39955118_39955269 | 13.29 |
Gm44992 |
predicted gene 44992 |
22881 |
0.2 |
chr11_90255756_90255960 | 13.29 |
Mmd |
monocyte to macrophage differentiation-associated |
6382 |
0.23 |
chr17_5997468_5997674 | 13.18 |
Synj2 |
synaptojanin 2 |
725 |
0.67 |
chr10_111576755_111576942 | 13.16 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
17425 |
0.14 |
chr9_111144787_111144938 | 13.16 |
Lrrfip2 |
leucine rich repeat (in FLII) interacting protein 2 |
16441 |
0.16 |
chr10_76447965_76448118 | 13.12 |
2610028H24Rik |
RIKEN cDNA 2610028H24 gene |
1040 |
0.38 |
chr2_155610966_155611319 | 13.10 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
70 |
0.93 |
chr5_57743879_57744030 | 13.08 |
Gm42635 |
predicted gene 42635 |
19561 |
0.11 |
chr13_42258570_42258751 | 13.03 |
Edn1 |
endothelin 1 |
42816 |
0.15 |
chr9_102505196_102505352 | 13.01 |
Ky |
kyphoscoliosis peptidase |
476 |
0.74 |
chr9_110765651_110765847 | 13.01 |
Myl3 |
myosin, light polypeptide 3 |
112 |
0.94 |
chr14_32685223_32685377 | 12.94 |
3425401B19Rik |
RIKEN cDNA 3425401B19 gene |
7 |
0.85 |
chr16_16215687_16215991 | 12.94 |
Pkp2 |
plakophilin 2 |
2521 |
0.29 |
chr1_82267641_82267792 | 12.94 |
Irs1 |
insulin receptor substrate 1 |
23700 |
0.16 |
chr5_92745758_92746287 | 12.89 |
Gm20500 |
predicted gene 20500 |
9817 |
0.19 |
chr7_75387120_75387271 | 12.89 |
Gm10161 |
predicted pseudogene 10161 |
21140 |
0.17 |
chr4_137488772_137489450 | 12.87 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
20308 |
0.13 |
chr18_20670820_20670985 | 12.87 |
Ttr |
transthyretin |
5622 |
0.18 |
chr16_6086275_6086458 | 12.86 |
1700123O21Rik |
RIKEN cDNA 1700123O21 gene |
110781 |
0.07 |
chr11_86958220_86958412 | 12.86 |
Ypel2 |
yippee like 2 |
13708 |
0.18 |
chr4_142057481_142057956 | 12.82 |
Gm13053 |
predicted gene 13053 |
9140 |
0.13 |
chr18_54476905_54477056 | 12.81 |
Gm50361 |
predicted gene, 50361 |
215 |
0.95 |
chr14_55313710_55313928 | 12.81 |
Gm49022 |
predicted gene, 49022 |
33132 |
0.1 |
chr6_142485848_142485999 | 12.75 |
Ldhb |
lactate dehydrogenase B |
9725 |
0.18 |
chr12_73403432_73403592 | 12.69 |
D830013O20Rik |
RIKEN cDNA D830013O20 gene |
6045 |
0.18 |
chr4_126237755_126238091 | 12.61 |
Map7d1 |
MAP7 domain containing 1 |
2188 |
0.21 |
chr4_142126961_142127291 | 12.59 |
Kazn |
kazrin, periplakin interacting protein |
9015 |
0.17 |
chr4_43258690_43258841 | 12.53 |
Unc13b |
unc-13 homolog B |
1935 |
0.3 |
chr10_111936919_111937157 | 12.49 |
Krr1 |
KRR1, small subunit (SSU) processome component, homolog (yeast) |
35626 |
0.12 |
chr7_133731017_133731168 | 12.42 |
Dhx32 |
DEAH (Asp-Glu-Ala-His) box polypeptide 32 |
192 |
0.91 |
chr2_77182419_77182600 | 12.40 |
Ccdc141 |
coiled-coil domain containing 141 |
11873 |
0.2 |
chr2_59952440_59952598 | 12.39 |
Baz2b |
bromodomain adjacent to zinc finger domain, 2B |
4303 |
0.24 |
chr5_148272131_148272422 | 12.38 |
Mtus2 |
microtubule associated tumor suppressor candidate 2 |
6931 |
0.24 |
chr10_12354727_12354912 | 12.37 |
Gm23680 |
predicted gene, 23680 |
8591 |
0.16 |
chr16_50753146_50753367 | 12.35 |
Dubr |
Dppa2 upstream binding RNA |
20483 |
0.17 |
chr3_88125202_88125495 | 12.32 |
Mef2d |
myocyte enhancer factor 2D |
17024 |
0.09 |
chr19_4003174_4003335 | 12.15 |
Doc2g |
double C2, gamma |
59 |
0.89 |
chr6_29882005_29882158 | 12.12 |
Ahcyl2 |
S-adenosylhomocysteine hydrolase-like 2 |
5402 |
0.17 |
chr6_120174935_120175131 | 12.11 |
Ninj2 |
ninjurin 2 |
18790 |
0.18 |
chr9_118725275_118725441 | 12.11 |
Itga9 |
integrin alpha 9 |
13701 |
0.23 |
chr17_47759804_47759967 | 12.10 |
Tfeb |
transcription factor EB |
710 |
0.56 |
chr12_99609809_99609990 | 12.07 |
1700064M15Rik |
RIKEN cDNA 1700064M15 gene |
18075 |
0.12 |
chr2_91117863_91118209 | 12.06 |
Mybpc3 |
myosin binding protein C, cardiac |
108 |
0.94 |
chr14_99010735_99010909 | 12.03 |
Rpl36a-ps1 |
ribosomal protein L36A, pseudogene 1 |
16504 |
0.16 |
chr8_73343070_73343256 | 12.02 |
Large1 |
LARGE xylosyl- and glucuronyltransferase 1 |
9393 |
0.29 |
chr8_122145054_122145249 | 11.92 |
Zfp469 |
zinc finger protein 469 |
113469 |
0.04 |
chr15_12714458_12714609 | 11.88 |
Gm24302 |
predicted gene, 24302 |
19409 |
0.14 |
chr8_76972128_76972297 | 11.82 |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
63940 |
0.12 |
chr3_67372839_67373202 | 11.80 |
Mlf1 |
myeloid leukemia factor 1 |
1077 |
0.47 |
chr17_21289806_21289957 | 11.77 |
Vmn1r236 |
vomeronasal 1 receptor 236 |
3348 |
0.12 |
chr11_100967499_100967650 | 11.77 |
Cavin1 |
caveolae associated 1 |
2977 |
0.18 |
chr11_94229703_94229863 | 11.76 |
Wfikkn2 |
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 |
12924 |
0.16 |
chr8_45650070_45650222 | 11.72 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
8146 |
0.21 |
chr1_40805490_40805643 | 11.72 |
Tmem182 |
transmembrane protein 182 |
35 |
0.97 |
chr17_73072258_73072451 | 11.72 |
Lclat1 |
lysocardiolipin acyltransferase 1 |
35631 |
0.16 |
chr14_74657363_74657541 | 11.65 |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A |
16612 |
0.21 |
chr5_122071067_122071238 | 11.55 |
Cux2 |
cut-like homeobox 2 |
21050 |
0.12 |
chr11_70221528_70222219 | 11.52 |
Slc16a13 |
solute carrier family 16 (monocarboxylic acid transporters), member 13 |
809 |
0.35 |
chr14_54966795_54967354 | 11.49 |
Myh6 |
myosin, heavy polypeptide 6, cardiac muscle, alpha |
147 |
0.84 |
chr17_15462268_15462438 | 11.47 |
Gm49669 |
predicted gene, 49669 |
2548 |
0.19 |
chr1_133068333_133068592 | 11.45 |
Gm28609 |
predicted gene 28609 |
57 |
0.57 |
chr8_128679845_128680004 | 11.44 |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
5730 |
0.19 |
chr18_38929411_38929704 | 11.42 |
Fgf1 |
fibroblast growth factor 1 |
85 |
0.97 |
chr11_67790279_67790439 | 11.40 |
Dhrs7c |
dehydrogenase/reductase (SDR family) member 7C |
7828 |
0.17 |
chr4_147897388_147897711 | 11.36 |
Gm13156 |
predicted gene 13156 |
3876 |
0.12 |
chr2_35259420_35259608 | 11.26 |
Gsn |
gelsolin |
3065 |
0.2 |
chr10_74271130_74271281 | 11.24 |
Pcdh15 |
protocadherin 15 |
31946 |
0.26 |
chr14_16497447_16497656 | 11.17 |
Top2b |
topoisomerase (DNA) II beta |
72123 |
0.09 |
chr10_7274467_7274702 | 11.11 |
Cnksr3 |
Cnksr family member 3 |
62347 |
0.13 |
chr13_54177494_54177645 | 11.08 |
Hrh2 |
histamine receptor H2 |
14560 |
0.16 |
chr5_114134307_114134557 | 11.05 |
Ung |
uracil DNA glycosylase |
2352 |
0.17 |
chr13_12320274_12320453 | 11.05 |
Actn2 |
actinin alpha 2 |
20361 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.0 | 40.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
6.7 | 20.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
5.4 | 5.4 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
4.6 | 13.9 | GO:0031034 | myosin filament assembly(GO:0031034) |
4.4 | 13.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
4.2 | 4.2 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
3.7 | 18.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
3.5 | 10.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
3.4 | 13.7 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
3.4 | 23.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
3.0 | 23.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.9 | 2.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
2.9 | 5.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.7 | 8.1 | GO:0007525 | somatic muscle development(GO:0007525) |
2.7 | 8.1 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
2.6 | 2.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
2.5 | 5.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
2.3 | 6.9 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.3 | 6.9 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
2.2 | 13.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
2.0 | 2.0 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
2.0 | 5.9 | GO:0030421 | defecation(GO:0030421) |
2.0 | 3.9 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.9 | 9.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.9 | 11.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.8 | 7.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.8 | 5.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.7 | 3.5 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.7 | 17.4 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
1.7 | 5.1 | GO:0032439 | endosome localization(GO:0032439) |
1.7 | 8.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.7 | 5.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.6 | 13.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.6 | 4.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.6 | 9.4 | GO:0015671 | oxygen transport(GO:0015671) |
1.6 | 23.4 | GO:0014850 | response to muscle activity(GO:0014850) |
1.5 | 4.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.5 | 4.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.5 | 4.5 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.5 | 5.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.4 | 27.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
1.4 | 4.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.4 | 5.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.4 | 12.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.4 | 5.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.3 | 4.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.3 | 4.0 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.3 | 5.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.3 | 18.0 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
1.3 | 8.9 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
1.3 | 8.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.2 | 2.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.2 | 2.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.2 | 8.6 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
1.2 | 2.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.2 | 3.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.2 | 34.7 | GO:0045214 | sarcomere organization(GO:0045214) |
1.2 | 3.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.2 | 4.8 | GO:0007296 | vitellogenesis(GO:0007296) |
1.2 | 1.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.2 | 1.2 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
1.2 | 3.5 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.1 | 2.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.1 | 3.4 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.1 | 4.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.1 | 1.1 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.1 | 3.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.0 | 3.0 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.0 | 5.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.0 | 1.9 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
1.0 | 4.8 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.9 | 1.9 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.9 | 2.8 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.9 | 0.9 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.9 | 3.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.9 | 14.6 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.9 | 3.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.9 | 3.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.9 | 2.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.9 | 7.0 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.9 | 2.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.9 | 2.6 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.8 | 0.8 | GO:0048382 | mesendoderm development(GO:0048382) |
0.8 | 2.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.8 | 2.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.8 | 2.5 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.8 | 5.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.8 | 3.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.8 | 2.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.8 | 4.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.8 | 2.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.8 | 4.8 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.8 | 2.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.8 | 2.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.8 | 2.3 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.8 | 2.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.7 | 2.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 3.0 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.7 | 5.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.7 | 1.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.7 | 32.4 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.7 | 2.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.7 | 2.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.7 | 2.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.7 | 7.2 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.7 | 10.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.7 | 2.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.7 | 10.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.7 | 2.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.7 | 2.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.7 | 3.5 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.7 | 1.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.7 | 1.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.7 | 9.6 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.7 | 0.7 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 4.8 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.7 | 0.7 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.7 | 2.0 | GO:0001757 | somite specification(GO:0001757) |
0.7 | 2.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 3.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.7 | 4.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.7 | 2.6 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.7 | 0.7 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.7 | 1.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.7 | 3.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.6 | 2.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.6 | 1.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 3.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.6 | 1.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.6 | 3.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.6 | 2.5 | GO:0019230 | proprioception(GO:0019230) |
0.6 | 7.3 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.6 | 1.8 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 1.8 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.6 | 3.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.6 | 2.4 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.6 | 3.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.6 | 1.2 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.6 | 2.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.6 | 1.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.6 | 1.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.6 | 1.8 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.6 | 1.2 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.6 | 2.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 1.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.6 | 1.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.6 | 0.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 0.6 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.6 | 1.1 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.6 | 2.8 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.6 | 2.3 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.6 | 23.6 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.6 | 1.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.6 | 6.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.6 | 1.7 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.6 | 4.4 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.5 | 1.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.5 | 1.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.5 | 3.2 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.5 | 2.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.5 | 1.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.5 | 2.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.5 | 2.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.5 | 1.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.5 | 1.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.5 | 1.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.5 | 2.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.5 | 2.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.5 | 1.6 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.5 | 1.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.5 | 2.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.5 | 1.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.5 | 0.5 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.5 | 2.6 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.5 | 2.0 | GO:0032898 | neurotrophin production(GO:0032898) |
0.5 | 2.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 0.5 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
0.5 | 1.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.5 | 4.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 1.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 2.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 2.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.5 | 1.0 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.5 | 1.5 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.5 | 1.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.5 | 2.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.5 | 3.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.5 | 4.4 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.5 | 2.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.5 | 0.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.5 | 2.4 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.5 | 1.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.5 | 1.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.5 | 1.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 0.9 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 1.8 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.5 | 6.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.5 | 1.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.5 | 2.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 1.8 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 1.4 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.5 | 1.4 | GO:0071674 | mononuclear cell migration(GO:0071674) |
0.5 | 1.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.5 | 0.9 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 1.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 0.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.4 | 1.3 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.4 | 0.9 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.4 | 6.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.4 | 0.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 0.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 0.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.4 | 0.9 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 7.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 2.2 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 1.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 11.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 0.4 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.4 | 2.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 0.4 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 0.9 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.4 | 0.4 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.4 | 1.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.4 | 5.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 2.6 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.4 | 1.3 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 0.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 3.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 0.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 1.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 0.4 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.4 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 0.4 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 1.7 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.4 | 2.5 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 0.4 | GO:0044531 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
0.4 | 3.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 2.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.4 | 1.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.4 | 7.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 1.6 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.4 | 2.0 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.4 | 1.6 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.4 | 0.8 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.4 | 2.0 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.4 | 3.6 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.4 | 1.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 1.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.4 | 0.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.4 | 2.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 1.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.4 | 1.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 2.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.4 | 2.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.4 | 1.2 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.4 | 1.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 2.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 2.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 1.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 7.0 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.4 | 1.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 0.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 0.8 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.4 | 1.2 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.4 | 1.9 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.4 | 7.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 0.4 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 2.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 1.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.4 | 3.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 3.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 0.4 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.4 | 0.8 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.4 | 1.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 2.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 0.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.4 | 1.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 1.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 1.5 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.4 | 1.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 4.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.4 | 4.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.4 | 1.8 | GO:0042246 | tissue regeneration(GO:0042246) |
0.4 | 0.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.4 | 4.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.4 | 1.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.4 | 1.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 0.4 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 0.7 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.4 | 0.7 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.4 | 1.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.4 | 0.7 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.4 | 0.4 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.4 | 0.4 | GO:0071947 | protein K29-linked deubiquitination(GO:0035523) protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 1.8 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.4 | 1.4 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.4 | 1.8 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 2.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 2.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 1.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.3 | 4.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 9.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 1.0 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.3 | 4.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 4.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.3 | 2.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 1.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 4.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.3 | 0.3 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.3 | 2.7 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 2.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 1.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 1.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.3 | 3.7 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 1.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 5.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.3 | 1.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 0.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 0.7 | GO:0030578 | PML body organization(GO:0030578) |
0.3 | 3.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 2.3 | GO:0048747 | muscle fiber development(GO:0048747) |
0.3 | 1.0 | GO:1901570 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.3 | 2.0 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 1.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 7.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 2.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 1.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 1.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 1.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 2.9 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 0.3 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.3 | 1.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 1.6 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.3 | 1.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 2.9 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.3 | 3.5 | GO:0031100 | organ regeneration(GO:0031100) |
0.3 | 0.6 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.3 | 0.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.3 | 0.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.3 | 0.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.3 | 1.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 5.1 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.3 | 0.3 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.3 | 0.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 0.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 1.9 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.3 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 0.9 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.3 | 0.3 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 15.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 1.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 0.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.3 | 1.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.9 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.3 | 1.5 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.3 | 1.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 1.2 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.3 | 0.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 3.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.3 | 2.2 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.3 | 0.6 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 0.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 1.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 0.6 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 2.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 1.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 0.3 | GO:0032885 | regulation of polysaccharide biosynthetic process(GO:0032885) |
0.3 | 0.9 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 0.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.3 | 1.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 2.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.3 | 2.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 0.3 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.3 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 2.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.3 | 5.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 0.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 4.7 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 3.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 0.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.3 | 1.8 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.3 | 2.3 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.3 | 1.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 2.0 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.3 | 0.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 1.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 | 2.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.3 | 3.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 1.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 0.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 1.7 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.3 | 0.6 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 0.9 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 1.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 0.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 0.8 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 0.8 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.3 | 1.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 2.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 1.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 0.3 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 3.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 0.8 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.3 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 0.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.3 | 0.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 1.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 1.1 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.3 | 1.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 0.3 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.3 | 0.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 1.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.8 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 0.8 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 1.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 2.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.3 | 1.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.5 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 6.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 4.5 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.3 | 3.2 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.3 | 0.5 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 4.5 | GO:0033198 | response to ATP(GO:0033198) |
0.3 | 0.3 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.3 | 0.5 | GO:0003321 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.3 | 0.8 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 1.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 1.6 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.3 | 1.3 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.3 | 1.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 10.4 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.3 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 0.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 0.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 16.9 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.3 | 2.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 0.3 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.3 | 0.3 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.3 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 0.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 0.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 1.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 1.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.3 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.3 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 0.8 | GO:0000237 | leptotene(GO:0000237) |
0.3 | 3.8 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 0.5 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 0.7 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 1.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 2.7 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 0.7 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.2 | 1.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 1.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.7 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 0.5 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.2 | 0.5 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 0.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.2 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 2.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 4.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 0.2 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 1.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 6.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.2 | 6.3 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.2 | 0.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 5.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.2 | 1.0 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 3.8 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.2 | 0.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 1.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.7 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.2 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 2.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 6.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 1.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.5 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.7 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 5.6 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.2 | 0.2 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.2 | 0.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.2 | 0.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 1.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 0.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.5 | GO:0031058 | positive regulation of histone modification(GO:0031058) |
0.2 | 0.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 8.9 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.2 | 10.0 | GO:0007041 | lysosomal transport(GO:0007041) |
0.2 | 23.9 | GO:0006936 | muscle contraction(GO:0006936) |
0.2 | 3.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.5 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 4.3 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 0.2 | GO:0032309 | icosanoid secretion(GO:0032309) |
0.2 | 0.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 0.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 3.8 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.4 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 5.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 0.2 | GO:0097484 | dendrite extension(GO:0097484) |
0.2 | 0.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.2 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 1.3 | GO:0035809 | regulation of urine volume(GO:0035809) positive regulation of urine volume(GO:0035810) |
0.2 | 0.2 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.2 | 0.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.9 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 1.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 1.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.2 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 3.0 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.2 | 0.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.2 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 0.2 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.2 | 0.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.2 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.2 | GO:0014856 | skeletal muscle cell proliferation(GO:0014856) |
0.2 | 1.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.2 | 0.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.9 | GO:0080111 | DNA demethylation(GO:0080111) |
0.2 | 0.8 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.2 | GO:0051458 | corticotropin secretion(GO:0051458) positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.4 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 0.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 2.5 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.2 | 0.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 0.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 2.9 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.2 | 0.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.2 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.2 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 4.5 | GO:0048538 | thymus development(GO:0048538) |
0.2 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 1.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.6 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 5.2 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 0.4 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.2 | 0.4 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.8 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.4 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.2 | 1.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 1.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.6 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 1.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.2 | 1.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.8 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.2 | 0.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 2.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.8 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.4 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.2 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.8 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 1.3 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.2 | 1.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 0.6 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 1.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 0.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 1.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.4 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.2 | 1.9 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.2 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.4 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 2.9 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.2 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 6.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 8.0 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.2 | 1.3 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.2 | 0.5 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.2 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 1.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.7 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.4 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.9 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.2 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.2 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.2 | 0.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.3 | GO:0071025 | RNA surveillance(GO:0071025) |
0.2 | 0.5 | GO:0050931 | pigment cell differentiation(GO:0050931) |
0.2 | 0.3 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.2 | 0.2 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.2 | 0.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 1.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.3 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 1.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.5 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 0.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 1.5 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.2 | 0.3 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.2 | 0.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.2 | 0.3 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
0.2 | 1.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 3.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.5 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.2 | 1.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.7 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) |
0.2 | 1.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase II promoter(GO:0042795) snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.7 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 24.6 | GO:0007517 | muscle organ development(GO:0007517) |
0.2 | 0.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 16.4 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 0.5 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.2 | 1.0 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.2 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 1.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 2.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.3 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 0.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 1.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.5 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.2 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.2 | 0.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 1.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 2.6 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.2 | 0.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.2 | 0.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 1.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 8.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 1.6 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.2 | 0.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 0.6 | GO:0060425 | lung morphogenesis(GO:0060425) |
0.2 | 0.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 0.8 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 2.3 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 0.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.6 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.2 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 17.9 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.2 | 0.2 | GO:0002576 | platelet degranulation(GO:0002576) |
0.2 | 0.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 7.1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.2 | 1.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 1.2 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 2.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 9.1 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.2 | 0.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.2 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.3 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.8 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.9 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 1.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 1.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 1.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.6 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 11.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.3 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 0.3 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 1.3 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.1 | GO:0003157 | endocardium development(GO:0003157) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 1.0 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.1 | 1.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.3 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) |
0.1 | 0.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.3 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 | 0.3 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.1 | GO:0060920 | sinoatrial node development(GO:0003163) cardiac pacemaker cell differentiation(GO:0060920) sinoatrial node cell differentiation(GO:0060921) |
0.1 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 2.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.3 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 1.3 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.7 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 3.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.1 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.1 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 2.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 1.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 1.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 1.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.3 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 4.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.7 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.9 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 1.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.1 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.1 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.3 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 0.5 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.4 | GO:0032768 | regulation of monooxygenase activity(GO:0032768) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 3.4 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.5 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 1.7 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.1 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
0.1 | 0.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 1.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 1.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 3.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.4 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.6 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 4.0 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.1 | 0.9 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.2 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.1 | 0.9 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 1.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.5 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 1.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.5 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.7 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 1.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.2 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.0 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 1.2 | GO:0030431 | sleep(GO:0030431) |
0.1 | 0.4 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.1 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 0.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.2 | GO:0042454 | ribonucleoside catabolic process(GO:0042454) |
0.1 | 0.7 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 1.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.7 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.9 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 1.5 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.3 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.1 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.1 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.1 | 1.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.7 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.1 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.6 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.3 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 1.9 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 2.1 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.1 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.2 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.1 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.2 | GO:0090179 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 0.1 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 10.5 | GO:0006575 | cellular modified amino acid metabolic process(GO:0006575) |
0.1 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.5 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.9 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 1.8 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.5 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 1.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.2 | GO:0002739 | cytokine secretion involved in immune response(GO:0002374) regulation of cytokine secretion involved in immune response(GO:0002739) |
0.1 | 2.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.1 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.6 | GO:0016233 | telomere capping(GO:0016233) |
0.1 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 2.8 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.2 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.2 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.1 | 0.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 1.5 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 1.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 1.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.2 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 1.6 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 1.5 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.3 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.1 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 1.2 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 1.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.1 | GO:0071312 | cellular response to alkaloid(GO:0071312) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.2 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.3 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.3 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.3 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 1.5 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 1.6 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.3 | GO:1903313 | positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 1.5 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.2 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.3 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.1 | 3.6 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.1 | 0.3 | GO:0000087 | mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.1 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.1 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.1 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.6 | GO:0035094 | response to nicotine(GO:0035094) |
0.1 | 0.2 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.1 | 0.7 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 1.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.2 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.1 | 0.1 | GO:0048679 | regulation of axon regeneration(GO:0048679) |
0.1 | 0.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.1 | 1.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.2 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 0.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.7 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.2 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.2 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.1 | 0.5 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.1 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.1 | 1.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.1 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 2.5 | GO:0007338 | single fertilization(GO:0007338) |
0.1 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.2 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.9 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 2.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 1.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 1.2 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.1 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.5 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.1 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 2.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.1 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.5 | GO:0003281 | ventricular septum development(GO:0003281) |
0.1 | 0.2 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 1.1 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.1 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 5.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.3 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.1 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.4 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.8 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.4 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.5 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 1.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.5 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.8 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.6 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 1.0 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.6 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.9 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.1 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.1 | GO:0044851 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.1 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:1903333 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.1 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.1 | 1.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) |
0.1 | 0.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.4 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.1 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.1 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.0 | GO:1902896 | terminal web assembly(GO:1902896) |
0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.0 | 0.0 | GO:0035930 | corticosteroid hormone secretion(GO:0035930) regulation of corticosteroid hormone secretion(GO:2000846) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.0 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) ketone body metabolic process(GO:1902224) |
0.0 | 0.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.0 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 1.9 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.0 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.4 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.1 | GO:0010665 | regulation of cardiac muscle cell apoptotic process(GO:0010665) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.1 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.0 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.2 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0044845 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 2.0 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.0 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.4 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.2 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.1 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.0 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.6 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.0 | 0.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.0 | 0.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.3 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.7 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.0 | 0.0 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.1 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.2 | GO:0010810 | regulation of cell-substrate adhesion(GO:0010810) |
0.0 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:0052805 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) D-amino acid metabolic process(GO:0046416) |
0.0 | 0.1 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.0 | 0.5 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.0 | 0.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.0 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 0.1 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.2 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.4 | GO:0030595 | leukocyte chemotaxis(GO:0030595) |
0.0 | 0.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.0 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.0 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.0 | 0.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.2 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.0 | 0.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.1 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.2 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 5.7 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 1.2 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.8 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.0 | 0.0 | GO:1903391 | regulation of adherens junction organization(GO:1903391) |
0.0 | 0.0 | GO:1901859 | regulation of mitochondrial DNA replication(GO:0090296) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.0 | 0.1 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.1 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.0 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0098597 | vocal learning(GO:0042297) imitative learning(GO:0098596) observational learning(GO:0098597) learned vocalization behavior or vocal learning(GO:0098598) |
0.0 | 0.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.0 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.0 | 0.1 | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
0.0 | 0.0 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 0.1 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.1 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.1 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.0 | 0.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.5 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 0.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.1 | GO:0021924 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.0 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.0 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.2 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.0 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:1901888 | regulation of cell junction assembly(GO:1901888) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 1.1 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.1 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.0 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.1 | GO:0090504 | epiboly(GO:0090504) |
0.0 | 0.1 | GO:1901380 | negative regulation of potassium ion transmembrane transport(GO:1901380) |
0.0 | 0.0 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.0 | 0.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 0.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.0 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.0 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.0 | 0.0 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.0 | 0.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.0 | 0.3 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 0.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.0 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.0 | 0.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.7 | GO:0006906 | vesicle fusion(GO:0006906) |
0.0 | 0.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.0 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 0.1 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.0 | 0.0 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.0 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.0 | 1.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.0 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.0 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.0 | GO:2000677 | regulation of transcription regulatory region DNA binding(GO:2000677) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.0 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.0 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.0 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.0 | 0.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.0 | 0.3 | GO:0046323 | glucose import(GO:0046323) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.1 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.0 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.0 | 0.1 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.0 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.0 | 0.0 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.0 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.3 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.1 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.0 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.0 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.0 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.0 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.0 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.0 | 0.0 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.0 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.1 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.1 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.0 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.0 | 0.0 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 21.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
6.1 | 18.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
6.0 | 18.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
5.6 | 16.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.4 | 31.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
3.1 | 18.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
3.0 | 9.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.9 | 8.6 | GO:0005914 | spot adherens junction(GO:0005914) |
2.5 | 33.1 | GO:0005916 | fascia adherens(GO:0005916) |
2.4 | 7.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
2.4 | 19.0 | GO:0005861 | troponin complex(GO:0005861) |
2.1 | 10.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.9 | 9.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.8 | 9.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.7 | 7.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.6 | 6.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.5 | 4.4 | GO:0031417 | NatC complex(GO:0031417) |
1.4 | 4.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.4 | 62.5 | GO:0016459 | myosin complex(GO:0016459) |
1.4 | 113.5 | GO:0030018 | Z disc(GO:0030018) |
1.3 | 17.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.1 | 1.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.0 | 5.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.9 | 5.6 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.9 | 10.3 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.9 | 5.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.9 | 9.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.8 | 1.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.8 | 5.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.8 | 7.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 14.0 | GO:0002102 | podosome(GO:0002102) |
0.8 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.8 | 2.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.7 | 3.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 12.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.7 | 2.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.7 | 4.8 | GO:0045179 | apical cortex(GO:0045179) |
0.7 | 2.7 | GO:0031430 | M band(GO:0031430) |
0.7 | 2.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.7 | 3.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.6 | 2.6 | GO:0000938 | GARP complex(GO:0000938) |
0.6 | 14.1 | GO:0090544 | BAF-type complex(GO:0090544) |
0.6 | 2.6 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 1.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.6 | 3.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.6 | 0.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.6 | 1.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.6 | 1.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.6 | 10.7 | GO:0030057 | desmosome(GO:0030057) |
0.6 | 5.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.6 | 5.3 | GO:0043034 | costamere(GO:0043034) |
0.6 | 2.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 0.6 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.6 | 1.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.5 | 3.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.5 | 2.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 2.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 1.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.5 | 2.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.5 | 8.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 2.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 0.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 3.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 4.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 1.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 4.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.4 | 2.0 | GO:0016342 | catenin complex(GO:0016342) |
0.4 | 2.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 1.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.4 | 2.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.4 | 3.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 7.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.4 | 3.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 3.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 1.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 1.8 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 3.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 5.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 2.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 0.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 5.4 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 1.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 8.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 2.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 1.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 2.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 9.5 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 4.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 1.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 2.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 0.9 | GO:0005712 | chiasma(GO:0005712) |
0.3 | 4.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 3.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 3.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 3.6 | GO:0031011 | Ino80 complex(GO:0031011) |
0.3 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 0.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 0.9 | GO:0043205 | fibril(GO:0043205) |
0.3 | 0.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 0.9 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 2.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 0.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 2.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 1.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 16.4 | GO:0005884 | actin filament(GO:0005884) |
0.3 | 0.8 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 0.8 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 2.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 6.2 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 1.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 2.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 1.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 0.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 1.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 0.8 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 0.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 2.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 6.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.3 | 14.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 3.8 | GO:0001741 | XY body(GO:0001741) |
0.2 | 5.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 2.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 18.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 1.7 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 7.6 | GO:0030016 | myofibril(GO:0030016) |
0.2 | 0.9 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 13.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 6.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 1.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 2.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 8.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 1.1 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 8.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 2.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 2.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 0.2 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.2 | 2.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.4 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 2.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 2.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 0.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 0.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 1.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 2.2 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.8 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.2 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 0.4 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.2 | 32.2 | GO:0031965 | nuclear membrane(GO:0031965) |
0.2 | 28.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 3.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 0.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.2 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 2.0 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 2.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 0.2 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.2 | 7.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 26.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.2 | 1.0 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.2 | GO:0000801 | central element(GO:0000801) |
0.2 | 0.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 1.9 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 13.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 8.8 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 3.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 11.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 1.8 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 9.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 1.6 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 6.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 0.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 3.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 2.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 2.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 8.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 1.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 0.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 2.0 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 1.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 2.0 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 1.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 2.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 1.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 6.9 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 9.7 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 1.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.6 | GO:0000803 | sex chromosome(GO:0000803) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 1.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.8 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 3.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.8 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 1.1 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 5.8 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 2.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 1.0 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 1.0 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 24.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 2.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 4.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 3.2 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 1.3 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.1 | 3.7 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 1.3 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 1.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 4.5 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 7.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 9.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.8 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 1.2 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 1.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.2 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 0.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.1 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.1 | 0.5 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.4 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 2.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.3 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.6 | GO:0030990 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.1 | 0.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 9.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 6.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 1.2 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 5.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 1.0 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 1.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.9 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 1.7 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 1.2 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.6 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.6 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 17.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.1 | GO:0044448 | cell cortex part(GO:0044448) |
0.1 | 5.1 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.1 | 2.6 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 1.6 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 6.0 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.2 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 1.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 6.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 6.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 1.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.3 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 2.0 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 3.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.1 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 39.4 | GO:0005856 | cytoskeleton(GO:0005856) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 1.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 2.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.9 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 25.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 4.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.1 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 3.6 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 2.0 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 1.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.0 | 0.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 2.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 3.9 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 0.0 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.6 | 34.3 | GO:0031433 | telethonin binding(GO:0031433) |
4.9 | 14.8 | GO:0051373 | FATZ binding(GO:0051373) |
4.0 | 8.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
4.0 | 27.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
3.0 | 14.9 | GO:0031013 | troponin I binding(GO:0031013) |
2.1 | 8.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
2.1 | 6.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
2.0 | 16.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.9 | 15.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.9 | 9.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.9 | 5.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.8 | 5.4 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.8 | 35.3 | GO:0003785 | actin monomer binding(GO:0003785) |
1.6 | 14.8 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.6 | 8.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.6 | 9.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.5 | 4.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.5 | 17.7 | GO:0044548 | S100 protein binding(GO:0044548) |
1.5 | 30.7 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.4 | 17.3 | GO:0031005 | filamin binding(GO:0031005) |
1.4 | 8.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.4 | 8.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.4 | 12.5 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.4 | 4.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.4 | 4.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.3 | 8.0 | GO:0031432 | titin binding(GO:0031432) |
1.3 | 5.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.3 | 11.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.3 | 1.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
1.2 | 3.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.2 | 4.8 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.2 | 5.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.2 | 3.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.1 | 3.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.0 | 3.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.0 | 5.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.0 | 4.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.0 | 3.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.0 | 6.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.0 | 2.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.0 | 10.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.0 | 2.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 3.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.9 | 13.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.9 | 1.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.8 | 0.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.8 | 2.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 3.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.8 | 0.8 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.8 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 2.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.8 | 17.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.8 | 4.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.8 | 3.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.8 | 2.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.8 | 22.7 | GO:0043236 | laminin binding(GO:0043236) |
0.8 | 3.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.7 | 3.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.7 | 2.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.7 | 2.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.7 | 2.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.7 | 1.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 0.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.7 | 2.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.7 | 4.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 2.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.7 | 2.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.7 | 7.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.7 | 2.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.7 | 7.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.7 | 2.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.7 | 2.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.7 | 1.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.6 | 8.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.6 | 0.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.6 | 5.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 10.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.6 | 5.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 2.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 4.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.6 | 3.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 21.0 | GO:0043531 | ADP binding(GO:0043531) |
0.6 | 7.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 2.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 2.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.6 | 10.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 2.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 3.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.6 | 2.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.6 | 1.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.5 | 2.2 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.5 | 2.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.5 | 1.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 1.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.5 | 9.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 3.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 2.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 2.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 7.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 1.5 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.5 | 4.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.5 | 3.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.5 | 1.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.5 | 5.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 2.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 2.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 1.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.5 | 1.0 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 1.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 0.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 2.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 2.4 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.5 | 1.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 1.4 | GO:2001069 | glycogen binding(GO:2001069) |
0.5 | 17.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.5 | 2.3 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.5 | 5.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.5 | 10.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 1.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 1.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 4.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 1.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 1.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.5 | 1.8 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 0.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 4.8 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.4 | 2.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 1.3 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.4 | 1.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 3.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 2.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 0.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 0.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 6.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.4 | 3.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.4 | 2.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 1.2 | GO:0015265 | urea channel activity(GO:0015265) |
0.4 | 1.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.4 | 3.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 2.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 0.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 1.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 1.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 1.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.4 | 1.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 1.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 6.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.4 | 0.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.4 | 1.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.4 | 1.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 16.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.4 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 2.6 | GO:0052812 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.4 | 0.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.4 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 1.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.4 | 6.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.4 | 0.7 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 3.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 1.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 1.5 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 9.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.4 | 1.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 2.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 0.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.4 | 1.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 1.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 1.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 1.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 1.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 5.5 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 4.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 1.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 1.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 2.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 1.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 4.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 1.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 6.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 2.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 2.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 1.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 3.0 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 2.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 1.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 1.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 1.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 87.7 | GO:0003779 | actin binding(GO:0003779) |
0.3 | 0.6 | GO:0019198 | transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 0.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 1.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 2.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 5.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 5.5 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 15.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.3 | 1.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.3 | 0.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 2.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 1.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 3.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 0.3 | GO:0001226 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.3 | 3.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 0.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 4.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 0.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 0.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 0.6 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 1.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 0.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 1.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 0.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 6.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 0.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 0.6 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 0.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 1.4 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 3.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 1.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 1.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.3 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.3 | 17.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 1.3 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 0.8 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 0.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 1.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 1.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 8.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 8.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 3.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 2.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 1.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 1.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 1.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 0.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 2.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 3.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 6.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 1.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 1.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 9.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 5.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 80.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 14.3 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.4 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 1.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 1.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 1.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 5.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 3.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 1.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 3.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 3.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.8 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 1.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 5.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 5.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 4.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 1.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 2.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 1.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 1.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.2 | 2.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 1.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 6.9 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 0.8 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 2.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.2 | 1.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 3.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 1.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 0.2 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.2 | 1.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 1.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.7 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 0.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 2.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 29.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 1.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 1.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 1.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.8 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.2 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 1.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 3.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.2 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 0.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 1.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 1.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 0.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 1.1 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.2 | 2.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 2.9 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 1.1 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 1.3 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 1.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 1.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 6.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 1.3 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 4.3 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.3 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 1.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 5.9 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 1.5 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.7 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 5.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.7 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 3.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 1.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 11.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 3.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.7 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 2.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 7.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 3.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.2 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 2.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.5 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 5.2 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 1.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.9 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 3.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 2.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 1.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.8 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 1.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.9 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.4 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 4.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 3.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 1.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 2.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 1.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 1.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 1.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.7 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.4 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.5 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.5 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.1 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.2 | GO:0019113 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.8 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.2 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 15.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 1.0 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 2.8 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.6 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 4.9 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 1.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.8 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.4 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 3.2 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.6 | GO:0052773 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 0.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.2 | GO:0097617 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 3.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.2 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.5 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 3.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 6.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.2 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.9 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 1.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 4.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 1.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.0 | 0.3 | GO:0036442 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 1.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 2.2 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.3 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.0 | 11.7 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 1.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0051379 | epinephrine binding(GO:0051379) |
0.0 | 0.5 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.2 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.8 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 4.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 1.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.4 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 2.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 11.9 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.0 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.0 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.0 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.2 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.0 | 0.0 | GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.0 | 0.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.0 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.0 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.0 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 1.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.6 | 1.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.0 | 14.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.9 | 9.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.8 | 1.7 | ST GAQ PATHWAY | G alpha q Pathway |
0.8 | 3.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.7 | 4.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 16.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.5 | 7.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 22.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 7.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 20.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.5 | 25.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.5 | 6.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.4 | 10.5 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 10.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 10.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 5.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 10.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 15.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 8.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.4 | 15.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 13.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 2.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 1.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 1.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 5.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 0.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 12.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 4.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 1.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 2.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 10.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 7.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 1.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 7.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 5.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 12.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 3.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 2.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 4.5 | PID ATM PATHWAY | ATM pathway |
0.2 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 5.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 5.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 3.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 1.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 1.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 2.6 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 3.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 2.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 2.4 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 3.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 1.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 1.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 0.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 1.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 1.9 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 2.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 2.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 2.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 4.5 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.1 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 3.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 19.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 2.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 4.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 3.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 4.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 86.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.7 | 5.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.7 | 30.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.5 | 16.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.4 | 25.9 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
1.3 | 14.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.0 | 3.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.8 | 16.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.8 | 19.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.7 | 7.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 6.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.6 | 8.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 4.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 1.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.5 | 2.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.5 | 6.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 5.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 8.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 15.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.5 | 5.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 3.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 9.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 2.3 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.4 | 14.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 3.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.4 | 3.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 10.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 2.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 2.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 2.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 9.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.4 | 3.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 12.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 0.7 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.3 | 2.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 2.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 1.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.3 | 3.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 2.5 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 2.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.3 | 4.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 5.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 1.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 4.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 2.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 3.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 3.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 3.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 4.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 5.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 1.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 9.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 2.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 3.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 2.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 3.3 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 2.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 2.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 3.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 0.2 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.2 | 8.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 5.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 8.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 0.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 0.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 1.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 1.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 2.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 15.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 2.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 5.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 4.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 6.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 2.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 1.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 5.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 4.0 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 2.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 3.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 1.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 3.8 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.2 | 0.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 7.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 2.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 1.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 3.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 8.3 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.2 | 0.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 9.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 5.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 1.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 1.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 2.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 1.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 1.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 2.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 6.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 8.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 3.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 12.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 5.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.5 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 2.2 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 2.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 3.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 2.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.2 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.1 | 1.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 16.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 9.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 2.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.5 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 0.5 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 1.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 3.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.5 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.1 | 0.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 4.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 2.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 6.7 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 2.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 1.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.0 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.0 | 0.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.2 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.2 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |